Search

Your search keyword '"Shukla, Sachet A"' showing total 384 results

Search Constraints

Start Over You searched for: Author "Shukla, Sachet A" Remove constraint Author: "Shukla, Sachet A"
384 results on '"Shukla, Sachet A"'

Search Results

1. Epigenomic charting and functional annotation of risk loci in renal cell carcinoma

2. Germline variants associated with toxicity to immune checkpoint blockade

3. Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect

4. ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

5. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer

8. Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma

9. Genetic mechanisms of immune evasion in colorectal cancer

10. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

11. Enriched Signalling Pathways in Venetoclax-Relapsed Chronic Lymphocytic Leukemia (CLL) Cells and Targeting Using a Protac-Based Bcl-2/Bcl-Xl Degrader

12. Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

13. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia

14. Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit

15. Cellular and molecular determinants of limited anti-tumor immunity in chromophobe renal carcinoma (ChRCC).

16. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer

17. Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

18. Characterization of the Cellular Origin and Oncogenic Mechanisms of Chromophobe Renal Cell Carcinoma (ChRCC) and Renal Oncocytic Neoplasms

19. Abstract PR015: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma

20. Abstract A013: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma

21. Abstract B019: Clinical and molecular characterization of chromophobe renal cell carcinoma: A focus on immunotherapy based regimens and the tumor immune microenvironment

22. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

24. Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

25. A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens

26. Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma

27. The Somatic Genomic Landscape of Glioblastoma

29. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

30. Comprehensive genomic characterization of squamous cell lung cancers

31. Data from Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors

32. Supplementary Figures Legends from Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors

33. Supplementary Tables from Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors

35. Supplementary Tables 1-7 from Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System

36. Supplementary Methods and Figures 1-5 from Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System

37. Supplementary Table S7 from The Genomic Landscape of Pediatric Ewing Sarcoma

38. Data from microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma

39. Supplementary Tables 1-10 from microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma

40. Supp. Table S22 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

41. Supplementary Methods, Figure Legends, Figures S1 - S6, Tables S1, S3 - S6, S8 - S15, S17 from The Genomic Landscape of Pediatric Ewing Sarcoma

42. Data from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

43. Supplementary Figures 1-13 from microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma

45. Supp. Tables S1, S3-S15, S20, and S23 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

46. Supplementary Methods, Figure Legends 1-13, Table Legends 1-10 from microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma

47. Supp. Tables S16-S19 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

48. Data from Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System

49. Supp. Figures and Legends from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

50. Supplementary Figure from Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma

Catalog

Books, media, physical & digital resources